Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Decagon Asset Management LLP reported a 5.52% stake in Oaktree Acquisition Corp. Iii Life Sciences (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Decagon Asset Management LLP reported a 5.52% stake in Oaktree Acquisition Corp. Iii Life Sciences, 1,091,327 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.52%
- Shares
- 1,091,327
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Decagon Asset Management LLP | 5.52% | 1,091,327 |
| Benjamin John Durham | 5.52% | 1,091,327 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Decagon Asset Management LLP
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13G/A · Barclays PLC · Feb 11, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2025